| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/08/2002 | US20020106776 pth |
| 08/08/2002 | US20020106773 Protein-protein interactions in neurodegenerative diseases |
| 08/08/2002 | US20020106771 Nucleic acids encoding CLK protein kinases |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 08/08/2002 | US20020106742 Nucleic acids encoding active and inactive CCR5 chemokine receptors |
| 08/08/2002 | US20020106740 Nucleotide sequences coding membrane protein for use in treatment asthma, Parkinson's disease, heart defects, hypotension, urogenital disorders and osteoporosis |
| 08/08/2002 | US20020106738 Novel Siglec gene |
| 08/08/2002 | US20020106735 Novel Bcl-2 related proline rich protein (BPR) |
| 08/08/2002 | US20020106732 Smad6 and uses thereof |
| 08/08/2002 | US20020106731 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of apoptosis and inflammation defects |
| 08/08/2002 | US20020106729 Nucleotide sequences for use as tools in genetic engineering |
| 08/08/2002 | US20020106728 NS4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders |
| 08/08/2002 | US20020106726 Peptide for use in the treatment of inflammation defects |
| 08/08/2002 | US20020106724 RNA-binding protein |
| 08/08/2002 | US20020106723 Receptor for latrotoxin from insects |
| 08/08/2002 | US20020106705 Detection method for monitoring beta tubulin isotype specific modification |
| 08/08/2002 | US20020106695 Human tumor necrosis factor delta and epsilon |
| 08/08/2002 | US20020106676 Nucleotide sequence coding preferential protein for use in the treatment of nervous system disorders |
| 08/08/2002 | US20020106650 Nucleotide sequence coding preferential polypeptide; for use in the treatment, prevention and diagnosis of kidney, liver, reproductive and cardiovascular disorders |
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/08/2002 | US20020106639 Postweaning multisystemic wasting syndrome virus from pigs |
| 08/08/2002 | US20020106636 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 08/08/2002 | US20020106629 Genetically engineering preferential immunoglobulins in cells; obtain cells, transform with vector containing genetically engineered immunoglobulin, recover transformed cells, propagate, recover immunoglobulin |
| 08/08/2002 | US20020106397 Inoculating female birds withimmunogen, harvesting eggs which contain antibodies to immunogen, drying egg contents and adding to feed or water for host animals for inhibiting ability of immunogen to adhere to rumen or intestinal tracts |
| 08/08/2002 | US20020106383 For immunizing animals |
| 08/08/2002 | US20020106374 Compositions and methods for inhibition of HIV-1 infection |
| 08/08/2002 | US20020106372 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 08/08/2002 | US20020106371 For therapy of sytematic lupus erythematosus, primary biliary cirrhosis, and idiopathic thrombocytopenic purpura |
| 08/08/2002 | US20020106370 Improvements in or relating to peptide delivery |
| 08/08/2002 | US20020106369 Method of inhibiting stenosis and restenosis |
| 08/08/2002 | US20020106324 Treating cancer whereof the cells exhibit overexpression of a product of a gene of the myc-related family |
| 08/08/2002 | CA2784251A1 Focused libraries of genetic packages |
| 08/08/2002 | CA2766160A1 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | CA2444661A1 Use of cd23 antagonists for the treatment of neoplastic disorders |
| 08/08/2002 | CA2437021A1 Adiponectin-associated protein |
| 08/08/2002 | CA2436661A1 Novel nucleic acid and polypeptide molecules |
| 08/08/2002 | CA2436530A1 Environmentally regulated genes of streptococcus suis |
| 08/08/2002 | CA2436411A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 08/08/2002 | CA2436403A1 Anti-rubeola antibody for treating crohn's disease |
| 08/08/2002 | CA2436281A1 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | CA2436092A1 Modified antibodies and methods of use |
| 08/08/2002 | CA2434953A1 Protein modification and maintenance molecules |
| 08/08/2002 | CA2432867A1 A novel human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/07/2002 | EP1229125A1 Process for producing polypeptide |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1229116A1 Method for preparing cell fraction containing hemangioblasts |
| 08/07/2002 | EP1229043A1 Peptides derived from Epstein Barr virus (EBV) proteins LMP1, LMP2 and BARF1 antibody reagents reactive therewith |
| 08/07/2002 | EP1228768A1 Medicament for the protection against thrombotic diseases |
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228210A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228087A1 Antibody catalysis of enantio- and diastereo-selective aldol reactions |
| 08/07/2002 | EP1228086A1 PROCESS FOR CORRECTION OF A DISULFIDE MISFOLD IN Fc MOLECULES |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1227843A2 Method and system to remove cytokine inhibitor in patients |
| 08/07/2002 | EP1227842A1 Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5 |
| 08/07/2002 | EP1227841A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP0972015A4 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 08/07/2002 | EP0906576B1 Prostate cancer specific antibodies for immunodetection and immunotherapy |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | CN1362970A Monoclonal antibody against estrogen-stimulated leucine aminopeptidase |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362418A Anticholera vibrio, its toxic chicken yolk antibody and the prepn and application |
| 08/06/2002 | US6429360 Plant pest control |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429295 Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 08/06/2002 | US6429290 Modulation of body weight; diagnosis; dietetics; gene expression; drug screening |
| 08/06/2002 | US6429289 Class BI and CI scavenger receptors |
| 08/06/2002 | US6429286 Immunoregulatory molecules for costimulatory signal transduction |
| 08/06/2002 | US6429230 Treating chronic uremic patients undergoing periodical dialysis |
| 08/06/2002 | US6429187 Method of diagnosing and treating gliomas |
| 08/06/2002 | US6429186 Ligand antagonists for treatment of breast cancer |
| 08/06/2002 | US6429004 Transforming or transfecting a cell with a vector containing a polynucleotide which encodes a polypeptide having amidase activity useful for the production of optically active compounds |
| 08/06/2002 | US6428980 Involved in cell cycle regulation for use in assays screening for cell cycle modulators and use as therapeutics for controlling apoptosis, cell proliferation, etc. in disease states or for wound healing |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 08/06/2002 | US6428952 Methods and kits employing LAV antigens for the detection of HIV-1-specific antibodies |
| 08/06/2002 | US6428788 Preferential drug delivery to tumors having interleukin receptors; side effect reduction |
| 08/06/2002 | US6428787 TNF inhibitors for the treatment of retinal disorders |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/06/2002 | CA1341381C Yeast hybrid vectors and their use for the production of polypeptides |
| 08/02/2002 | WO2001055207A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2395738A1 Nucleic acids, proteins, and antibodies |
| 08/01/2002 | WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | WO2002059607A2 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059377A2 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 08/01/2002 | WO2002059340A1 Immunopolypeptides to hepatitis c virus |
| 08/01/2002 | WO2002059327A2 Sulfatases and methods of use thereof |
| 08/01/2002 | WO2002059326A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |